Abstract
The role of mitochondrial DNA (mtDNA) in the expression of the transformed phenotype was examined using mtDNA-less HeLa cells. Complete depletion of mtDNA and its products in the mtDNA-less HeLa cell line, EB8, was confirmed by Southern blot analysis and by [35S]methionine labeling of mitochondrially synthesized polypeptides. The tumorigenicity of the EB8 cells was assayed by inoculation of 1×107 cells subcutaneously into the backs of nude mice. The results showed that the tumorigenicity of HeLa cells was lost in good correspondence with the loss of mtDNA. However, the growth of EB8 cells in culture was very poor compared with that of HeLa cells, indicating that the apparent loss of tumorigenicity in EB8 cells could possibly be due to poor growth of the cells. Introduction of mtDNA from normal human fibroblasts into EB8 cells restored both the missing tumorigenicity and growth of the EB8 cells. These observations could be interpreted to show that mtDNA is required for expression of tumorigenicity, but that mutational changes of the mtDNA are not required for modulation of the phenotype in our experiments.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Literature cited
Pederson, P.L. (1978). InProceedings, Experimental Tumor Research, Vol. 22, (ed.) Wallach, D.F.H. (S. Karger AG, Basel), pp. 190–274.
Wilkinson, R., Hawks, A., and Pegg, A.N. (1975).Chem.-Biol. Interact. 9157–167.
Allen, J.A., and Coombs, M.M. (1980).Nature 287244–245.
Backer, J.M., and Weinstein, I.B. (1980).Science 209297–299.
Niranjan, B.G., Bhat, N.K., and Aradhani, N.G. (1982).Science 21573–75.
Shay, J.W., and Werbin, H. (1987).Mutat. Res. 186149–160.
Hayashi, J.-I., Yonekawa, H., and Tagashira, Y. (1989).Cancer Res. 494715–4720.
Mita, S., Monnat, R.J., Jr., and Loeb, L.A. (1988).Cancer Res. 484578–4583.
Segal-Bendirdjian, E., Coulaud, D., Roques, B.P., and Le Pecq, J.-B. (1988).Cancer Res. 484982–4992.
Van den Bogert, C., Dontje, B.H.J., and Kroon, A.M. (1983).Cancer Res. 432247–2251.
Van den Bogert, C., Dontje, B.H.J., Holtrop, M., Melis, T.E., Romijn, J.C., Van Dongen, J.W., and Kroon, A.M. (1986).Cancer Res. 463283–3289.
Zinkewich-Péotti, K., Parent, M., and Morais, R. (1990).Cancer Res. 506675–6682.
King, M.P., and Attardi, G. (1989).Science 246500–503.
Hayashi, J.-I., Yonekawa, H., Watanabe, S., Nonaka, I., Momoi, M.Y., Kagawa, Y., and Ohta, S. (1991). InProgress in Neuropathology, Vol. 7, (eds.) Sato, T., and DiMauro, S., (Raven Press, New York), pp. 93–102.
Hayashi, J.-I., and Murakami, J. (1988).Mol. Gen. Genet. 211381–385.
Mariottini, P., Chomyn, A., Riley, M., Cottrell, B., Doolittle, R.F., and Attardi, G. (1986).Proc. Natl. Acad. Sci. U.S.A. 831563–1567.
Seligman, A.M., Karnovsky, M.J., Wasserkrug, H.L., and Hanker, J.S. (1968).J. Cell Biol. 381–14.
Hayashi, J.-I., Werbin, H., and Shay, J.W. (1986).Cancer Res. 464001–4006.
Hayashi, J.-I., Yonekawa, H., Murakami, J., Tagashira, Y., Pereira-Smith, O.M., and Shay, J.W. (1987).Exp. Cell Res. 172218–227.
Moraes, C.T., Shanske, S., Tritschler, H.-J., Aprille, J.R., Andreetta, F., Bonilla, E., Schon, E.A., and DiMauro, S. (1991).Am. J. Hum. Genet. 48492–501.
Croce, C. (1980).Biochim. Biophys. Acta. 605411–430.
Sager, R. (1985).Adv. Cancer Res. 4443–68.
Hayashi, J.-I., Tagashira, Y., Watanabe, T., and Yoshida, M.C. (1984).Cancer Res. 443957–3960.
Richter, C. (1988).FEBS Lett. 2411–5.
Shay, J.W., and Werbin, H. (1990). InMechanisms of Differentiation, Vol. I, (ed.) Fisher, P.B. (CRC Press, Boca Raton, Florida), pp. 135–159.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hayashi, JI., Takemitsu, M. & Nonaka, I. Recovery of the missing tumorigenicity in mitochondrial DNA-less HeLa cells by introduction of mitochondrial DNA from normal human cells. Somat Cell Mol Genet 18, 123–129 (1992). https://doi.org/10.1007/BF01233159
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF01233159